Insider Transactions
| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Sep 30, 2016 |
Director
Trans History: 75
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 173 | $136.29 | 2,978 |
| Sep 30, 2016 |
Director
Trans History: 90
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 134 | $136.29 | 4,134 |
| Sep 30, 2016 |
Director
Trans History: 160
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 167 | $136.29 | 34,066 |
| Sep 30, 2016 |
Director
Trans History: 157
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 206 | $136.29 | 19,977 |
| Mar 12, 2015 |
Senior Vice President
Trans History: 161
|
Senior Vice President | Form 4 | Open market or private sale of non-derivative or derivative security | 3,667 | $136.51 | 16,543 |
| Feb 22, 2017 |
Senior EVP
Trans History: 464
|
Senior EVP | Form 4 | Open market or private sale of non-derivative or derivative security | 16,696 | $136.79 | -- |
| Dec 12, 2019 |
Senior EVP
Trans History: 464
|
Senior EVP | Form 4 | Open market or private sale of non-derivative or derivative security | 4,000 | $137.15 | 4,889 |
| Dec 11, 2019 |
Senior EVP
Trans History: 464
|
Senior EVP | Form 4 | Open market or private sale of non-derivative or derivative security | 8,043 | $137.23 | 28,062 |
| Feb 25, 2020 |
EVP and CFO
Trans History: 74
|
EVP and CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 16,337 | $137.33 | 12,142 |
| Jan 15, 2020 |
EVP and CFO
Trans History: 74
|
EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 779 | $137.33 | 12,142 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.